Salarius Pharmaceuticals
SLRX
SLRX
33 hedge funds and large institutions have $21.7M invested in Salarius Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 2 closing their positions.
Holders
33
Holders Change
+1
Holders Change %
+3.13%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
11
Reduced
7
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $2K | 646 | -532 | -45% |
|
27
JPMorgan Chase & Co
New York
| $1K | 342 | – | – |
|
28
BNP Paribas Financial Markets
Paris,
France
| $24 | 7 | – | – |
|
29
Fidelity Investments
Boston,
Massachusetts
| – | – | -217,734 | Closed |
|
|
ECM
30
Element Capital Management
New York
| – | – | -16,855 | Closed |
|
31
Simplex Trading
Chicago,
Illinois
| $0 | 269 | -9,359 | -97% |
|
32
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 1 | – | – |
|
33
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $0 | 27 | – | – |
|
|
LTFS
34
Ladenburg Thalmann Financial Services
Miami,
Florida
| $0 | 100 | – | – |
|
35
Barclays
London,
United Kingdom
| $0 | 88 | – | – |
|